NCT06084806View on ClinicalTrials.gov

Test-retest Evaluation of [18F]F-AraG PET

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

[18F]F-ARAG PET

Two imaging sessions

Trial Locations (1)

52246

RECRUITING

University of Iowa Hospitals and Clinics, Iowa City

Sponsors
All Listed Sponsors
collaborator

University of Iowa

OTHER

lead

CellSight Technologies, Inc.

INDUSTRY

NCT06084806 - Test-retest Evaluation of [18F]F-AraG PET | Biotech Hunter | Biotech Hunter